cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Evolus Inc
11 own
8 watching
Current Price
$10.88
$-0.45
(-3.97%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
566.81M
52-Week High
52-Week High
15.43300
52-Week Low
52-Week Low
7.07000
Average Volume
Average Volume
0.65M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization566.81M
icon52-Week High15.43300
icon52-Week Low7.07000
iconAverage Volume0.65M
iconDividend Yield--
iconP/E Ratio--
What does the Evolus Inc do?
N/A
Read More
How much money does Evolus Inc make?
News & Events about Evolus Inc.
Business Wire
11 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has commenced the commercial launch of Nuceiva (botulinum toxin type A) in Italy. The product is now available for direct order and delivery to customers. Nuceiva is approved by the European...
Business Wire
12 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the completion of its Phase 2 clinical study evaluating an extra-strength dose for extended duration of Jeuveau (prabotulinumtoxinA-xvfs), its flagship...
Business Wire
1 year ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its first quarter 2023 financial results and provide a business update on Tuesday, May 9, 2023, after the U.S. financial...
Business Wire
1 year ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida. Event: Barclays...
Business Wire
1 year ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, has commenced the commercial launch of Nuceiva (botulinum toxin type A) in Germany and Austria, and is now available for direct order and delivery to customers...
Frequently Asked Questions
Frequently Asked Questions
What is Evolus Inc share price today?
plus_minus_icon
Can Indians buy Evolus Inc shares?
plus_minus_icon
How can I buy Evolus Inc shares from India?
plus_minus_icon
Can Fractional shares of Evolus Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Evolus Inc stocks?
plus_minus_icon
What is today’s traded volume of Evolus Inc?
plus_minus_icon
What is today’s market capitalisation of Evolus Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Evolus Inc?
plus_minus_icon
What percentage is Evolus Inc down from its 52-Week High?
plus_minus_icon
What percentage is Evolus Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.88
$-0.45
(-3.97%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00